Concepedia

Publication | Open Access

The role of PNI to predict survival in advanced hepatocellular carcinoma treated with Sorafenib

47

Citations

47

References

2020

Year

Abstract

PNI represents a prognostic tool in advanced HCC treated with first-line Sorafenib. It is readily available and low-cost, and it could be implemented in clinical practice in patients with HCC.

References

YearCitations

Page 1